A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...

Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back ...

Cancer rates in 2025 are predicted to exceed the previous year's statistics, with one-in-three men and women both at risk of contracting the disease.

The vaccine ELI-002 2P showed favorable relapse-free survival and overall survival in patients with pancreatic and colorectal ...

A new vaccine has shown promise in preventing pancreatic and colorectal cancer recurrence Read on to know about the study ...

A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic ...

A new off-the-shelf peptide vaccine has proven effective against pancreatic and colorectal cancer, reducing the chances of ...

A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The ...